Lifecore Biomedical Inc
NASDAQ:LFCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Starbucks Corp
NASDAQ:SBUX
|
US |
Lifecore Biomedical Inc
Operating Income
Lifecore Biomedical Inc
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
Operating Income
-$733k
|
CAGR 3-Years
69%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Hershey Co
NYSE:HSY
|
Operating Income
$1.5B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
|
Tyson Foods Inc
NYSE:TSN
|
Operating Income
$1.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-8%
|
|
|
Kellogg Co
NYSE:K
|
Operating Income
$1.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
|
Kraft Heinz Co
NASDAQ:KHC
|
Operating Income
$4.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
|
|
Mondelez International Inc
NASDAQ:MDLZ
|
Operating Income
$3.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
What is Lifecore Biomedical Inc's Operating Income?
Operating Income
-733k
USD
Based on the financial report for Dec 31, 2025, Lifecore Biomedical Inc's Operating Income amounts to -733k USD.
What is Lifecore Biomedical Inc's Operating Income growth rate?
Operating Income CAGR 5Y
29%
Over the last year, the Operating Income growth was 88%. The average annual Operating Income growth rates for Lifecore Biomedical Inc have been 69% over the past three years , 29% over the past five years .
